Lanzamiento Enero 2027

Estudio de cohortes2005Financiación no declarada

Low-density lipoprotein cholesterol and mortality in older people

Tikhonoff V, Casiglia E, Mazza A, Scarpa R, Thijs L, Pessina AC, Staessen JA

Journal of the American Geriatrics Society · 63 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Estudio de cohortes (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2005-10-06 · J Am Geriatr Soc · vol. 53 · número 12 · págs. 2159–2164
Editorial
Wiley
Citado
80 citas · más que el 93% de estudios similares · 3.8× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
32 trabajos
Acceso
Acceso abierto (copia en repositorio) · OTHER-OA
Áreas de investigación
Lipoproteins and Cardiovascular Health · Diabetes, Cardiovascular Risks, and Lipoproteins · Cardiovascular Health and Risk Factors
Palabras clave
LDL cholesterol, mortality, older adults, cardiovascular mortality, heart failure, myocardial infarction, stroke mortality, J-shaped relationship, cardiovascular risk factors, sex differences
MeSH
humans, cardiovascular diseases, myocardial infarction, mortality, proportional hazards models, risk factors, prospective studies, aged, aged, 80 and over, italy, female, male, cholesterol, ldl, heart failure, stroke

7 autores

  • Valérie Tikhonoff🇮🇹University of Padua
  • Edoardo Casiglia🇮🇹🇧🇪University of Padua; KU Leuven
  • Alberto Mazza🇮🇹🇧🇪University of Padua; KU Leuven
  • Roberta Scarpa🇮🇹🇧🇪University of Padua; KU Leuven
  • Lutgarde Thijs🇮🇹🇧🇪University of Padua; KU Leuven
  • Achille Cesare Pessina🇮🇹🇧🇪University of Padua; KU Leuven
  • Jan Albert Staessen🇮🇹🇧🇪University of Padua; KU Leuven

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objectives

To investigate the role of low-density lipoprotein cholesterol (LDL-C) as a predictor of mortality in elderly subjects.

Design

Population-based prospective cohort study.

Setting

Two communities in northern Italy.

Participants

Three thousand one hundred twenty Caucasian subjects aged 65 and older recruited in for the Cardiovascular Study in the Elderly and followed up for 12 years.

Measurements

Anthropometric measures: fasting plasma total cholesterol, triglyceride, high-density lipoprotein cholesterol, LDL-C, glucose, creatinine, and body mass index. Clinical measures: medical assessment, diabetes mellitus, hypertension, stroke, coronary disease, heart failure, and smoking and drinking habits. Vital status measures: death certificates from the Registry Office and causes of death according to the International Classification of Diseases. After plotting mortality rates using quartiles of LDL-C, relative hazard rates (RHRs) were calculated using multivariate Cox regression analyses. When the trend was nonlinear, the RHRs were further calculated for the 25th, 50th, and 75th percentiles of the distribution to confirm curvilinearity.

Results

The distribution of risk of total mortality in women and of fatal heart failure in all subjects was curvilinear (non J-shaped), decreasing nonlinearly with LDL-C. For total mortality in men and cardiovascular mortality in both sexes, the relationship with LDL-C was J-shaped. The risk of fatal myocardial infarction was J-shaped in men, whereas it increased linearly with higher LDL-C in women. In both sexes, the association between stroke mortality and LDL-C was not significant.

Conclusion

This study adds to the uncertainty of the role of elevated levels of LDL-C as a risk factor for mortality in old people.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.